Themenbereich / / Alternative

Sortiere PresseMitteilungen nach: Titel (A\D) Datum (A\D)

Seiten sind aktuell sortiert nach: Datum (erst neue PresseMitteilungen)

SANUWAVE Health to Host Conference Call to Provide Update on International Activity on Thursday, September 28, 2017

SUWANEE, GA -- (Marketwired) -- 09/25/17 -- (OTCQB: SNWV) announced today that the Company will host a conference call on Thursday, September 28, 2017, beginning at 9:00AM Eastern Time, to provide a business update on international activity and answer questions.Shareholders and other interested parties can participate in the conference call by dialing 866-682-6100 (U.S.) or 404-267-0373 (International) or via webcast at .A replay of the conference call will be available beginning two hours after its completion through December 27, 2017, by dialing 877-481-4010 (U.S.) or 919-882-2331 (Internat ...


BioElectronics Completes Subject Enrollment for Migraine Clinical Study; Migraine Prevention Using ActiPatch (Neuromodulation Therapy)

FREDERICK, MD -- (Marketwired) -- 09/25/17 -- BioElectronics Corporation (OTC PINK: BIEL), is pleased to report on the progress of its Migraine prevention clinical study. The randomized, double-blinded, sham-controlled study involving 48 subjects is designed to investigate if ActiPatch therapy can be used to prevent the frequency and intensity of migraine attacks. Since receiving IRB-approval for the protocol in May 2017, all 48 subjects needed to complete the study have been enrolled, as of September 20th, 2017.The principal investigator (PI) leading the study is Dr. Barry Eppley, M.D., D.M ...


Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

VANCOUVER, BC -- (Marketwired) -- 09/25/17 -- . (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce the signing of a Definitive Agreement with Solmic Research GmbH (Germany) in which Pivot will acquire worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic''s proprietary technology provides significantly higher bioavailability and stability compared to alternative oil-based formulations."Solmic is pleased to ...


Velano Vascular Adds Medical Device Industry Veterans to Leadership Team

SAN FRANCISCO, CA -- (Marketwired) -- 09/25/17 -- announced today that Drew Pieprzyk and Al Burdulis have joined the company''s executive leadership team as Vice President of Sales and Marketing and Vice President of Research and Development. Pieprzyk most recently served as Vice President of Global Marketing for the Teleflex ARROW® Vascular Access division, and Burdulis served as Vice President of Mechanical Systems for Spinal Modulation (acquired by St. Jude Medical/Abbott). The addition of these veteran medical and vascular technology executives will further enable the company t ...


Advantis Corp. Established Presence in Oregon Leads to New Contract

NEWPORT BEACH, CA -- (Marketwired) -- 09/24/17 -- ADVANTIS CORPORATION (OTC PINK: ADVT) is completing details on a contract with a private cannabis grower in Oregon to supply AmsterCan solutions. Advantis expects to supply the labor and canning machine to service a 40,000 square foot cultivation facility.In January 2016, Advantis, a California based company, went about establishing its presence on the rest of the west coast by creating an Advantis Cannabis, LLC in Washington and in Oregon. The plan at the time was to establish a west coast distribution hub for Advantis branded cannabis produc ...


Endonovo Therapeutics, Inc. and Kodiak Capital Group, LLC Announce Settlement and Dismissal of Lawsuit

LOS ANGELES, CA -- (Marketwired) -- 09/22/17 -- (OTCQB: ENDV) ("Endonovo" or the "Company"), a developer of non-invasive electroceuticals for the treatment of vascular diseases and inflammatory conditions, and Kodiak Capital Group, LLC ("Kodiak"), a private equity firm, today announced a settlement agreement and dismissal of complaints and cross-complaints arising out of a contemplated equity investment by Kodiak in Endonovo.The claims and cross-claims were negotiated and amicably resolved by the parties without any admission of wrongdoing. Kodiak is returning t ...


Eyetronic therapy: New milestone reached with 300 patients treated

BERLIN, GERMANY -- (Marketwired) -- 09/21/17 -- EBS Technologies, developer and provider of the system for the treatment of visual field loss, announces a new milestone: 300 patients have been treated with the therapy since its market introduction two years ago. Currently, six German eye centers offer patients affected by glaucoma or other optic neuropathies this new non-invasive optic nerve stimulation treatment.The therapy enables a completely new therapeutic approach to patients suffering from glaucoma and other conditions affecting the optic nerve. By applying gentle electrical pulses ...


Breathtec Biomedical Announces Resignation of Chief Executive Officer

VANCOUVER, BC -- (Marketwired) -- 09/20/17 -- (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF) announces that effective immediately, Guy La Torre has resigned as Director and Chief Executive Officer ("CEO") of the Company to pursue other ventures. The Company wishes Guy the best with his future endeavours. An interim CEO will be appointed in due course."Michael Sadhra" Chief Financial Officer & Director(CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI) (OTCQB: BTHCF)Breathtec Biomedical, Inc. ("Breathtec") was formed to propel innovative research in the area of ...


SHIEC Elects 2017-2018 Board of Directors

GRAND JUNCTION, CO -- (Marketwired) -- 09/20/17 -- a national trade association representing health information exchanges (HIEs), today announced the results of its board election held during the 2017 SHIEC Annual Conference. Board members were selected from its member base, with each of the 55 HIE members having a vote.The 2017-2018 board was expanded from nine to 12 members to reflect the growing stature of the organization and to account for the various perspectives of its growing member base."I''m very pleased to announce our new board," said Kelly Hoover Thompson, SH ...


SANUWAVE Announces Exhibition at Medica in Cooperation With State of Georgia; Visit us at Booth 16D10-8 in Hall 16

SUWANEE, GA -- (Marketwired) -- 09/20/17 -- (OTCQB: SNWV) is pleased to announce that the company will exhibit, in conjunction with Georgia Department of Economic Development, at MEDICA in Dusseldorf, Germany on 13 -16 November 2017. SANUWAVE cordially invites you to our section of booth 16D10-8 in Hall 16. MEDICA is the world''s leading trade fair for the medical industry. SANUWAVE is using this occasion to further educate on our lead wound care product, dermaPACE® and our industry leader for the treatment of various orthopedic conditions, orthoPACE®."We are very excited about ...


NetworkNewsWire Announces Publication Highlighting Recent Developments in Drug Delivery Technologies

NEW YORK, NY -- (Marketwired) -- 09/20/17 -- ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids.The publication, entitled, "Advances in Drug Delivery Hold the Promise of Reducing Inevitable Side Effects," discusses the potential of cannabinoids as efficient treatment options.To view the full ...


Protext Pharma Announces South Africa''s Reclassification of Cannabis as a Schedule 4 Substance

BOCA RATON, FL -- (Marketwired) -- 09/20/17 -- Protext Pharma, Inc. (PINKSHEETS: TXTM) ("Protext" or "the Company"), a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly-bioavailable plant extracts, today announced that the government of South Africa published recommended amendments to the Medical Innovation Bill that would change the status of cannabis products that do not have psychoactive properties from a Schedule 7 prohibited substance to a Schedule 4 substance. Schedule 4 drugs, which include antibiotics a ...


HemCare Health Services Appoints Telecom Veteran Daniel G. Cullen as Chief Technology Officer

LAS VEGAS, NV -- (Marketwired) -- 09/20/17 -- HemCare Health Services Inc. (OTC PINK: HCRE) is pleased to announce the appointment of Daniel G. Cullen as Chief Technology Officer. Mr. Cullen will be responsible for HemCare Health Services technology strategy and execution. In this capacity he will lead the company''s engineering and software development team and spearhead the company''s new technology initiatives in the application of Blockchain technology. Mr. Cullen will report directly to John Wilkes, CEO of Hemcare.Mr. Cullen is a Professional Engineer and senior manag ...


Dr. Patrick M. Fratellone Joins Canbiola, Inc. (CANB) as Medical Advisor and Distributor

HICKSVILLE, NY -- (Marketwired) -- 09/19/17 -- Canbiola, Inc. (OTC PINK: CANB) announced today that the company has added Dr. Fratellone to its Medical Advisory Board and engaged Dr. Fratellone as a distributor for Canbiola products. Dr. Fratellone is an attending physician at St. Luke''s Hospital, Roosevelt Hospital, and Beth Israel Hospital, and current professor at University of Bridgeport College of Naturopathic Medicine. In addition, he bridges East Meets West at the Center of Excellence in Bridgeport CT with author Dr. Peter D''Adamo of Eat Right for Your Blood Type. ...


Medovex Corporation Launches DenerveX System in Spain with Distributor Prim SA

ATLANTA, GA -- (Marketwired) -- 09/19/17 -- Medovex Corp. (NASDAQ: MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome related to back pain, today announced that it has launched its DenerveX System Device in Spain with leading distributor Prim SA.Spain is commonly referred to as one of the big five countries for Medtech in the EU with approximately 46 million people. Prim SA is a very large and well respected distributor that calls on the orthopedic and spine call point in ho ...


MetLife Hong Kong Expands Coverage for People with Diabetes and Introduces Insurtech Solution

HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- * announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. For the 1 in 10 people in Hong Kong living with diabetes, finding insurance cover that provides comprehensive coverage has historically been a challenge. MetLife Hong Kong''s inclusive action will make medical protection more accessible to this group of people.Mr. Lee Wood, Chief Executive Officer of MetLife Hong ...


Medigus Announces Second Quarter 2017 Financial Results

OMER, ISRAEL -- (Marketwired) -- 09/18/17 -- Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and direct visualization technology, today announced financial results for the second quarter ended June 30, 2017."This quarter, we continued our efforts of commercial expansion of MUSE™ into Europe and beyond -- an indication that we are on track to deliver on our long-term growth objectives," said Chris Rowland, CEO of Medigus. "Coupled with clinical trials performances in China and our continued reductions in expense ...


GeoVax Provides Update on its Zika Vaccine Development

ATLANTA, GA -- (Marketwired) -- 09/18/17 -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced that its Chief Scientific Officer, Farshad Guirakhoo, PhD, is delivering an updated presentation of results from studies of GeoVax''s NS-1 based Zika vaccine. Dr. Guirakhoo will deliver the talk, entitled "Development of a Novel Vaccine for Zika," today during the 11th Vaccine Congress in San Diego, CA.Dr. Guirakhoo is presenting research showing that a single intramuscular dose of GeoVax''s Zika vaccine gave 100% protection in ...


Organigram becomes one of the first licensed producers to sign MOU with provincial authority responsible for the distribution of cannabis to the adult recreational market

MONCTON, NEW BRUNSWICK -- (Marketwired) -- 09/15/17 -- HIGHLIGHTSOrganigram Holdings Inc. (TSX VENTURE: OGI)(OTCQB: OGRMF) (the "Company" or "Organigram"), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce that it has entered into a memorandum of understanding ("MOU") with the New Brunswick provincial authority for the distribution of marijuana to the adult-use recreational market.Through the MOU, New Brunswick secures a supply of at least 5 million grams of recreational marijuana per year from Organigram.The ...


Tauriga Sciences, Inc. Secures $210,000 in Long Term Financing from Existing Institutional Investor

NEW YORK, NY -- (Marketwired) -- 09/14/17 -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), a company engaged in building businesses in the life sciences space, today announced that it has secured $210,000 in long term financing from an existing institutional investor. Under terms of the financing agreement, the Company received $30,000 USD upon signing with the balance of $180,000 being deferred until after March 11, 2018. The financing structure consists of one $30,000 convertible debenture with 6 distinct $30,000 "Back End" convertible d ...


Page 1 from 169:  1 2  3  4  5  .. » 169

All members: 8 009
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 61

Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.